Rani Therapeutics Holdings, Inc.
RANI· Nasdaq
Released Nov 10, 2022, after the close
10-Q filed Nov 10, 2022, 41 days after period end · 0000950170-22-024442
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $108.00K |
| Net Income | -$7.96M | -$3.14M | -$2.88M |
| EPS Diluted | $0.33 | -$0.16 | — |
Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.